Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,791,518
+$523,356 QoQ
Shares Held
14,929
+11.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,818
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $24,607,939 across 14 Drug Manufacturers - General names. JNJ ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,041 | $4,846,897 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
14,929 | $3,791,518 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,511 | $3,149,663 | |
| 4 | NVS |
Novartis AG
|
13,900 | $2,178,408 | |
| 5 | AZN |
Astrazeneca PLC
|
11,123 | $2,109,143 | |
| 6 | ABBV |
AbbVie Inc.
|
7,480 | $1,882,267 | |
| 7 | PFE |
Pfizer Inc
|
66,535 | $1,602,162 | |
| 8 | AMGN |
Amgen Inc
|
3,219 | $1,165,664 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,791,518 | 14,929 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,268,162 | 13,370 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,805,000 | 13,554 | Shares | Defined | 2026-01-22 | |
| 2025-09-30 | $2,492,601 | 13,443 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,998,275 | 13,082 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,191,409 | 13,214 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,834,938 | 12,688 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $2,201,423 | 13,584 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,974,475 | 13,509 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,209,281 | 13,966 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,316,460 | 14,779 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,284,229 | 14,666 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,239,651 | 13,531 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,098,700 | 13,540 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,420,281 | 13,701 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,366,432 | 14,486 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $2,563,066 | 14,439 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $2,553,352 | 14,407 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $2,439,116 | 14,258 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,140,521 | 13,254 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,133,712 | 12,952 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $2,104,501 | 12,805 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $1,878,487 | 11,936 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,832,117 | 12,306 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $1,290,139 | 9,174 | Shares | Defined | 2020-08-03 | |
| 2020-03-31 | $1,012,061 | 7,718 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||